Browse

You are looking at 1 - 10 of 12 items for :

  • Public policy x
  • Refine by Content Type: News x
Clear All Modify Search

Temperature changes, shifting precipitation patterns, and increasing vector-human contact have led to a wider prevalence of kidney diseases across the world.

Congressional support is paramount for increasing investment in kidney health research at NIDDK, more funding for KidneyX to accelerate innovation, and protections for living organ donors.

Ryan Murray

AAKHI_3.PNGThe American Society of Nephrology (ASN) Department of Policy and Public Affairs team has received numerous questions from interested members and from the broader kidney community on the recent Executive Order on Advancing American Kidney Health and the accompanying Department of Health and Human Services report highlighting specific initiatives. In order to engage with our members, we will be running a series in Kidney News Online that addresses these questions. This is the second piece in that series.

Ryan Murray

AAKHI_0.PNGThe American Society of Nephrology (ASN) Department of Policy and Public Affairs team has received numerous questions from interested members and from the broader kidney community on the recent Executive Order on Advancing American Kidney Health and the accompanying Department of Health and Human Services report highlighting specific initiatives. In order to engage with our members, we will be running a series in Kidney News Online that addresses these questions. This is the first piece in that series.

ASN Staff

The American Society of Nephrology (ASN) is hosting an exclusive webinar on the Advancing American Kidney Health initiative on Wednesday, July 24, 2019, from 2:00-2:45 p.m. EDT.

Hear an overview of the Executive Order launching the initiative, an overview of the forthcoming new payment models, and discuss the report from the office of Assistant Secretary of Planning and Evaluation. The webinar is free to attend.

Raymond C Harris MD CoChair of the Kidney Health Initiative and John R Sedor MD Chair of the KidneyX Steering Committee

RRTRoadmapLogo_506x353_Twitter.jpg“We are going to prioritize a truly transformative goal: the development of an artificial kidney." - President Donald J. Trump

Last week, the Department of Health Human Services (HHS) and the White House announced a set of sweeping new policies, initiated by the leadership of HHS Secretary Alex Azar II, intended to improve the lives of the 37,000,000 people in the United States with kidney diseases. This is a nearly unprecedented level of government investment and national attention for kidney diseases. As a result, people with kidney diseases have real reason to hope that treatment options will improve for them and future kidney patients.

David White

Wednesday, July 10, the Trump administration will announce a new Department of Health and Human Services-wide (HHS) Comprehensive Kidney Care strategy. ASN and other kidney care groups have been working and meeting with Administration officials, including Secretary Alex M. Azar, II, all year providing input and recommendations for inclusion of in the new strategy.

ASN Staff

On Monday March 4th, Secretary Alex M. Azar II delivered a speech at the 6th Annual Kidney Patient Summit outlining both KidneyX and the strategic pillars of establishing an HHS-wide approach to comprehensive kidney care. ASN released a statement from ASN President Mark E. Rosenberg, MD, FASN, congratulating Secretary Azar and HHS on implementing this bold plan to better serve kidney disease patients and confirming ASN’s commitment to work together to achieve this goal.

Zachary Kribs

On Friday, September 28, President Donald Trump signed into law the annual Labor, Health and Human Services, and Education (LHHS) funding bill for Fiscal Year 2019, which contains multiple priorities of the American Society of Nephrology (ASN).

As reported in the August edition of Kidney News Online, these priorities include a $2 billion funding increase for the National Institutes of Health (NIH), and language supporting KidneyX, the study of immunosuppressive drug coverage for kidney transplant patients, Family and Medical Leave Act (FMLA) coverage for living organ donors, and recognition of the discrepancy between investment in kidney research and financial burden of kidney diseases.

Rachel Meyer

Last week, ASN joined other kidney community stakeholders to meet with leadership at the Centers for Medicare and Medicaid Services (CMS) in Baltimore, MD, to discuss the future of the ESRD Prospective Payment System—more commonly known as “the bundle”—that provides reimbursement for dialysis care.  Together with representatives from kidney patient organizations, dialysis organizations, and device manufacturers, ASN discussed with CMS the need for a mechanism to add new products to the bundle.